Invention Grant
US07750028B2 Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide
有权
1-（2,6-二氟苄基）-1H-1,2,3-三唑-4-甲酰胺的晶体改性
- Patent Title: Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide
- Patent Title (中): 1-（2,6-二氟苄基）-1H-1,2,3-三唑-4-甲酰胺的晶体改性
-
Application No.: US11329945Application Date: 2006-01-11
-
Publication No.: US07750028B2Publication Date: 2010-07-06
- Inventor: Robert Portmann , Urs C Hofmeier , Andreas Burkhard , Walter Scherrer , Martin Szelagiewicz
- Applicant: Robert Portmann , Urs C Hofmeier , Andreas Burkhard , Walter Scherrer , Martin Szelagiewicz
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Montgomery, McCracken, Walker & Rhoads, LLP
- Agent Kristin M. Nevins; Robert R. Axenfeld
- Priority: CH1404/97 19970610
- Main IPC: A61K31/4192
- IPC: A61K31/4192 ; C07D249/16
Abstract:
The invention relates to the novel modifications B and C of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of the formula its use and pharmaceutical preparations comprising this crystal modifications.
Public/Granted literature
- US20060116520A1 Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide Public/Granted day:2006-06-01
Information query
